微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 49.34% | 12.88% | 5.81% | 7/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 46.63% | 8.94% | -14.91% | 9/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 54.8% | 41.58% | 11.28% | 6/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 49.25% | 3.3% | 12.67% | 8/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 43.71% | 4.03% | 2.11% | 20/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 42.81% | 15.23% | 10.59% | 21/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 38.71% | 10.95% | -18.81% | 28/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 47.67% | 1.38% | 13.46% | 14/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 42.02% | -15.49% | 13.11% | 25/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 37.15% | -28.83% | 6.48% | 34/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 34.89% | -27.71% | -25.81% | 32/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 47.02% | -40.75% | -5.41% | 17/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 49.72% | -34.51% | -4.75% | 10/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 52.2% | -31.8% | 8.15% | 10/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 48.26% | -40.28% | -39.19% | 8/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 79.36% | -2.68% | 4.54% | 1/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 75.92% | -4.37% | -0.81% | 1/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 76.54% | -4.88% | -5.3% | 2/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 80.82% | 2.11% | -0.9% | 1/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 81.55% | 2% | 2.73% | 1/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 79.38% | 2% | -1.34% | 2/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 80.46% | 2% | 1.66% | 2/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 79.15% | 2% | 2% | 2/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |